Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine pamoate depot versus haloperidol decanoate for schizophrenia
2007-003342-15Phase 4Terminated
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in schizophrenia comparing Olanzapine pamoate depot with Haloperidol decanoate (2 arms). Primary endpoint: Time to all-cause discontinuation. Started Aug 2007; status: terminated.
02
Drugs
olanzapinehaloperidol
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2007-003342-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003342-15.